- ongoing, recruitingTherapeutic exploratory (Phase II)
C5541010 - A PHASE 2A, RANDOMIZED, DOUBLE BLIND, SPONSOR OPEN, PLACEBO CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF 07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY
This study is testing a new medicine, PF-07976016, to see if it helps adults with obesity lose weight safely. Participants will receive either the new medicine, a proven weight-loss drug called Saxenda, or a dummy medicine, to compare the effects.
Hungary · Poland - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults
This study is looking at a new medicine, PF-07976016, for people who are overweight or have obesity. It helps us understand how the body uses and gets rid of the medicine in healthy adult men. This is an early-stage study to check its safety and how it works.
Netherlands